Akums Drugs and Pharmaceutical (AKUMS) — Capital Reinvestment Ratio
Akums Drugs and Pharmaceutical (AKUMS) has a Capital Reinvestment Ratio of 0.59x as of March 2025, meaning it reinvests 1% of its operating cash flow (Rs4.65 Billion) in capital expenditures (Rs2.72 Billion). See net asset quality index of Akums Drugs and Pharmaceutical to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Akums Drugs and Pharmaceutical Capital Reinvestment Ratio (2022–2025)
This chart tracks Akums Drugs and Pharmaceutical's Capital Reinvestment Ratio across 4 annual periods. Check how aggressively does Akums Drugs and Pharmaceutical reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Akums Drugs and Pharmaceutical (2022–2025)
Year-by-year Capital Reinvestment Ratio for Akums Drugs and Pharmaceutical from 2022 to 2025. For live market cap and broader valuation context, see how much is Akums Drugs and Pharmaceutical worth.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.59x | Rs4.65 Billion | Rs2.72 Billion | ▼ -6.3% |
| 2024 | 0.62x | Rs4.98 Billion | Rs3.11 Billion | ▼ -66.4% |
| 2023 | 1.86x | Rs1.77 Billion | Rs3.29 Billion | ▼ -77.0% |
| 2022 | 8.09x | Rs318.54 Million | Rs2.58 Billion | — |